Clinical Trial Update: 24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels: A Prospective, Multicenter, Double-Blind, Placebo-Controlled Randomized Trial [NA]

View source ↗

Summary

A multicenter randomized trial evaluating 24 versus 12 months of dual antiplatelet therapy after drug-eluting stent implantation in patients with elevated lipop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Elevated Lipoprotein(a) Level, Coronary Artery Disease | NA | Status: RECRUITING